Additional Relevant Details Lombard Medical, a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced plans to conduct a 1,000 patient global registry to evaluate its new Altura Endograft System. The ALTITUDE registry (ALTuraImpact on the Treatment of Abdominal Aortic Aneurysms Using a Novel D-stent EVAR Design) will be conducted outsidethe United States and will evaluate the use of the Altura Endograft Stent System in real world patients across a range of clinical centers with a planned enrollment of 1,000 patients starting in late 2016.  The primary investigator will be Paul Hayes, MD, FRCS, of the Department of Surgery, University of Cambridge and Addenbrookes Hospital, Cambridge, UK.